Skip to main content

Advertisement

Table 1 Patient characteristics

From: Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors

Patient ID Age at time of CSF collection LP vs OM Sex Race Diagnosis CSF cytology MRI
1 42 LP F Unk Chiari I malformation N/A Neg
2 47 LP F W Aneurysm N/A Neg
3 56 LP F Unk Left trigeminal neuralgia. N/A Neg
4 37 LP F Unk Benign cyst N/A Neg
5 56 LP M W Motor neuron disease Neg Neg
6 52 LP F Unk Hydrocephalus Neg Neg
7 36 LP M AA Hydrocephalus Neg Neg
8 20 LP F Unk Pseudotumor cerebri Neg Neg
9 37 LP F W Glioblastoma,IDH-WT Neg Pos
10 56 LP M W Glioblastoma,IDH-WT Neg N/A
11 77 LP M His Glioblastoma,IDH-WT N/A N/A
12 61 LP F W Glioblastoma,IDH-WT Neg Pos
13 50 LP M W Glioblastoma,IDH-WT Neg Pos
14 47 LP M A Glioblastoma,IDH-WT N/A N/A
15 54 LP M A Glioblastoma,IDH-WT N/A N/A
16 76 LP F Unk Metastatic Lung Cancer Neg N/A
17 77 LP M A Metastatic Lung Cancer rare atypical cells Pos
18 60 LP F W Metastatic Lung Cancer Neg Pos
19 63 LP F W Metastatic Lung Cancer Neg Pos
20 70 LP M W Metastatic Lung Cancer Neg Pos
21 60 LP F Unk Metastatic Lung Cancer Neg Pos
22 61 LP F W Metastatic Lung Cancer Neg N/A
23 59 OM F A Metastatic breast cancer suspcious for lobular breast CA Neg
24 59 LP F His Metastatic breast cancer consistent with metastatic carcinoma Neg
25 62 LP F Unk Metastatic breast cancer negative Pos
26 38 LP F His Metastatic breast cancer negative Pos
27 73 OM F W Metastatic breast cancer negative Pos
28 28 LP M W Glioblastoma,IDH-mutant N/A N/A
29–30   OM     N/A N/A
31 56 LP M Unk Glioblastoma,IDH-mutant Neg Pos
32–33   OM     Neg Pos
34 32 LP M W Glioblastoma,IDH-mutant atypical cells present Pos
35–37   OM     Neg Pos
38 23 LP M W Glioblastoma,IDH-mutant Neg Pos
39–40   OM     Neg Pos